ロード中...
Safety of intranasal corticosteroids in acute rhinosinusitis
Treatment guidelines for acute rhinosinusitis (RS) recommend the use of intranasal corticosteroids (INSs) as monotherapy or adjunctive therapy. However, the adverse event (AE) profiles of oral glucocorticoids, which result largely from the systemic absorption of those agents, have engendered concern...
保存先:
| 出版年: | Am J Otolaryngol |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier Inc.
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7115254/ https://ncbi.nlm.nih.gov/pubmed/19144302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjoto.2007.11.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|